Interestingly, all the eight genes had increased expression levels in the high-risk samples, and the protein levels of SLC2A1, MMP14, TOP2A, ANLN, and SLC22A3 also increased in tumor samples compared with normal samples. This evidence concerns the gene SLC2A1 and neoplasm.